{"id":582,"date":"2016-10-25T15:38:33","date_gmt":"2016-10-25T15:38:33","guid":{"rendered":"https:\/\/www.labfit.pt\/hprd\/?p=582"},"modified":"2025-09-29T15:39:04","modified_gmt":"2025-09-29T15:39:04","slug":"meeting-of-the-eu-network-of-laboratories-for-the-validation-of-alternative-methods-eu-netval-sharing-practical-expertise-and-knowledge-on-in-vitro-methods","status":"publish","type":"post","link":"https:\/\/www.labfit.pt\/hprd\/2016\/10\/25\/meeting-of-the-eu-network-of-laboratories-for-the-validation-of-alternative-methods-eu-netval-sharing-practical-expertise-and-knowledge-on-in-vitro-methods\/","title":{"rendered":"Meeting of the EU Network of laboratories for the validation of alternative methods (EU-NETVAL): sharing practical expertise and knowledge on In Vitro methods"},"content":{"rendered":"\n\n\n<p>The European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) of the European Commission&#8217;s Joint Research Centre (JRC) hosted a two-day meeting with the members of the European Union Network of Laboratories for the Validation of Alternative Methods (EU-NETVAL) on the 10-11th October 2016.<\/p>\n\n\n\n<p><a href=\"https:\/\/ec.europa.eu\/jrc\/en\/news\/meeting-eu-network-laboratories-validation-alternative-methods-eu-netval-sharing-practical-expertise\">Link to the original article<\/a><\/p>\n\n\n\n<p>This year, EURL ECVAM welcomed 13 new test facilities to the network, including three from countries which were previously not represented within the network, bringing the total to 37 facilities from 15 different countries across Europe. The network holds a wide range of expertise and competences and includes laboratories experienced in advanced&nbsp;<em>in vitro<\/em>&nbsp;procedures, biological test systems and measurement techniques which are considered important to address specific aims and objectives identified in&nbsp;<a href=\"https:\/\/eurl-ecvam.jrc.ec.europa.eu\/eurl-ecvam-strategy-papers\">EURL ECVAM&#8217;s strategies<\/a>&nbsp;to achieve impact in the Replacement, Reduction, and Refinement of animal testing (the &#8216;three Rs&#8217;) in different areas of regulatory safety assessment.<\/p>\n\n\n\n<p>Representatives from test facilities which are supporting EURL ECVAM in various aspects of validation of&nbsp;<em>in vitro<\/em>&nbsp;methods engaged in a workshop related to the development of Good&nbsp;<em>In vitro<\/em>&nbsp;Method Practice (GIVIMP), an international project being led by JRC (EURL ECVAM) on behalf of the EU at the OECD. The purpose of this guidance is to contribute to increased standardisation, harmonisation and overall quality of&nbsp;<em>in vitro<\/em>&nbsp;studies that inform chemical and product safety assessment in a regulatory context.<\/p>\n\n\n\n<p>At the previous meeting in 2015, practical opportunities to share knowhow throughout the network were identified, with emphasis on the implementation of OECD Test Guidelines (TG) and novel&nbsp;<em>in vitro<\/em>&nbsp;methods. As a follow-up to this, the second day of the meeting this year was dedicated to knowledge sharing and training sessions organised in the EURL ECVAM laboratory. These practical sessions covered&nbsp;<em>in vitro<\/em>&nbsp;methods for assessing the skin sensitisation potential of chemicals and included the&nbsp;<a href=\"http:\/\/www.oecd-ilibrary.org\/test-no-442c-in-chemico-skin-sensitisation_5js6fpbt5z5g.pdf;jsessionid=3tdnot4q4k7fp.x-oecd-live-02?contentType=%2fns%2fOECDBook%2c%2fns%2fBook&amp;itemId=%2fcontent%2fbook%2f9789264229709-en&amp;mimeType=application%2fpdf&amp;containerItemId=%2fcontent%2fserial%2f20745788&amp;accessItemIds=&amp;option6=imprint&amp;value6=http%3a%2f%2foecd.metastore.ingenta.com%2fcontent%2fimprint%2foecd\">DPRA<\/a>,&nbsp;<a href=\"http:\/\/www.oecd-ilibrary.org\/test-no-442d-in-vitro-skin-sensitisation_5js6fpb0vk9x.pdf?contentType=%2fns%2fOECDBook%2c%2fns%2fBook&amp;itemId=%2fcontent%2fbook%2f9789264229822-en&amp;mimeType=application%2fpdf&amp;containerItemId=%2fcontent%2fserial%2f20745788&amp;accessItemIds=&amp;option6=imprint&amp;value6=http%3a%2f%2foecd.metastore.ingenta.com%2fcontent%2fimprint%2foecd\">KeratinoSens<\/a><sup>TM<\/sup>\/LuSens and&nbsp;<a href=\"http:\/\/www.oecd-ilibrary.org\/test-no-442e-in-vitro-skin-sensitisation_5jlsjc9pv0s4.pdf?contentType=%2fns%2fBook%2c%2fns%2fOECDBook&amp;itemId=%2fcontent%2fbook%2f9789264264359-en&amp;mimeType=application%2fpdf&amp;containerItemId=%2fcontent%2fserial%2f20745788&amp;accessItemIds=&amp;option6=imprint&amp;value6=http%3a%2f%2foecd.metastore.ingenta.com%2fcontent%2fimprint%2foecd\">h-CLAT<\/a>&nbsp;OECD TG methods. This marks the first of what will hopefully be many more collaborations within the network to share expertise and training to validate alternative&nbsp;<em>in vitro<\/em>&nbsp;methods and promote their use.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) of the European Commission&#8217;s Joint Research Centre (JRC) hosted a two-day meeting with the members of the European Union Network of Laboratories for the Validation of Alternative Methods (EU-NETVAL) on the 10-11th October 2016. Link to the original article This year, EURL ECVAM [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":426,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"saved_in_kubio":false,"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-582","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.labfit.pt\/hprd\/wp-json\/wp\/v2\/posts\/582","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.labfit.pt\/hprd\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.labfit.pt\/hprd\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.labfit.pt\/hprd\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.labfit.pt\/hprd\/wp-json\/wp\/v2\/comments?post=582"}],"version-history":[{"count":1,"href":"https:\/\/www.labfit.pt\/hprd\/wp-json\/wp\/v2\/posts\/582\/revisions"}],"predecessor-version":[{"id":583,"href":"https:\/\/www.labfit.pt\/hprd\/wp-json\/wp\/v2\/posts\/582\/revisions\/583"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.labfit.pt\/hprd\/wp-json\/wp\/v2\/media\/426"}],"wp:attachment":[{"href":"https:\/\/www.labfit.pt\/hprd\/wp-json\/wp\/v2\/media?parent=582"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.labfit.pt\/hprd\/wp-json\/wp\/v2\/categories?post=582"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.labfit.pt\/hprd\/wp-json\/wp\/v2\/tags?post=582"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}